These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30498365)

  • 1. Resistance phenotype and clinical molecular epidemiology of carbapenem-resistant
    Tian D; Pan F; Wang C; Sun Y; Zhang H
    Infect Drug Resist; 2018; 11():1935-1943. PubMed ID: 30498365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance Phenotype and Molecular Epidemiology of Carbapenem-Resistant
    Zhang WX; Chen HY; Chen C; Chen JH; Wan FS; Li LX; Chen M; Zhang J
    Microb Drug Resist; 2021 Oct; 27(10):1312-1318. PubMed ID: 34297609
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and Molecular Epidemiologic Characteristics of Ceftazidime/Avibactam-Resistant Carbapenem-Resistant
    Zhou J; Yang J; Hu F; Gao K; Sun J; Yang J
    Infect Drug Resist; 2020; 13():2571-2578. PubMed ID: 32801794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of carbapenem-resistant Klebsiella pneumoniae ST15 of producing KPC-2, SHV-106 and CTX-M-15 in Anhui, China.
    Zhao H; He Z; Li Y; Sun B
    BMC Microbiol; 2022 Nov; 22(1):262. PubMed ID: 36319965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
    Liu C; Liu L; Jin MM; Hu YB; Cai X; Wan L; Zhang HY; Li RY; Wu XJ
    Curr Med Sci; 2022 Feb; 42(1):68-76. PubMed ID: 34985611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Carbapenem-Resistant
    Han Y; Huang L; Liu C; Huang X; Zheng R; Lu Y; Xia W; Ni F; Mei Y; Liu G
    Infect Drug Resist; 2021; 14():767-773. PubMed ID: 33688212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Resistance Patterns, Sequence Types, Virulence and Carbapenemase Genes of Carbapenem-Resistant
    Shen M; Chen X; He J; Xiong L; Tian R; Yang G; Zha H; Wu K
    Infect Drug Resist; 2023; 16():637-649. PubMed ID: 36743338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of Carbapenem-resistant Klebsiella pneumoniae in a paediatric hospital in China.
    Wang B; Pan F; Wang C; Zhao W; Sun Y; Zhang T; Shi Y; Zhang H
    Int J Infect Dis; 2020 Apr; 93():311-319. PubMed ID: 32068096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-β-Lactamase-1.
    Dong F; Zhang Y; Yao K; Lu J; Guo L; Lyu S; Yang Y; Wang Y; Zheng H; Song W; Liu G
    Microb Drug Resist; 2018 Mar; 24(2):154-160. PubMed ID: 28594635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Epidemiology and Drug Resistant Mechanism of Carbapenem-Resistant
    Shao C; Wang W; Liu S; Zhang Z; Jiang M; Zhang F
    Front Public Health; 2021; 9():669173. PubMed ID: 34095072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outbreak of KPC-3 Producing Carbapenem-Resistant Klebsiella pneumoniae in a US Pediatric Hospital.
    Stillwell T; Green M; Barbadora K; Ferrelli JG; Roberts TL; Weissman SJ; Nowalk A
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):330-8. PubMed ID: 26582872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of carbapenemase producing Klebsiella pneumoniae strains by multiplex PCR and PFGE methods: The first K.pneumoniae isolates co-producing OXA-48/KPC and KPC/NDM in Turkey.
    Genç S; Kolaylı F; Özçelik EY
    J Infect Chemother; 2022 Feb; 28(2):192-198. PubMed ID: 34711509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of NDM-5-Producing Carbapenem-Resistant
    Li Q; Zhu J; Kang J; Song Y; Yin D; Guo Q; Song J; Zhang Y; Wang S; Duan J
    Infect Drug Resist; 2020; 13():3075-3089. PubMed ID: 32943891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro.
    Zhang J; Yu L; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Li C; Zhang X
    Ann Palliat Med; 2019 Nov; 8(5):622-631. PubMed ID: 31735038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence and nosocomial spread of ST11 carbapenem-resistant
    Chen CM; Guo MK; Ke SC; Lin YP; Li CR; Vy Nguyen HT; Wu LT
    J Med Microbiol; 2018 Jul; 67(7):957-964. PubMed ID: 29873627
    [No Abstract]   [Full Text] [Related]  

  • 16. The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China.
    Qin X; Wu S; Hao M; Zhu J; Ding B; Yang Y; Xu X; Wang M; Yang F; Hu F
    J Infect Dis; 2020 Mar; 221(Suppl 2):S206-S214. PubMed ID: 32176790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Clinical Cases of KPC-2-Producing
    Brahmia S; Lalaoui R; Nedjai S; Djahmi N; Chettibi S; Rolain JM; Bakour S
    Microb Drug Resist; 2021 May; 27(5):652-659. PubMed ID: 32991248
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of NDM-1 producing Klebsiella pneumoniae ST15 and ST147 in Iran during 2019-2020.
    Rad ZR; Rad ZR; Goudarzi H; Goudarzi M; Alizade H; Mazraeh FN; Sharahi JY; Ardebili A; Hashemi A
    Acta Microbiol Immunol Hung; 2021 May; ():. PubMed ID: 33974553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of molecular and clinical characteristics of carbapenem-resistant hypervirulent
    Lei J; Zhou WX; Lei K; Chen D; Zhang PQ; Xue L; Geng Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jan; 56(1):63-68. PubMed ID: 35092993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Resistance Genes and Molecular Epidemiological Characteristics of Carbapenem-Resistant
    Liao Y; Gong J; Yuan X; Lu H; Jiang L
    Infect Drug Resist; 2023; 16():1511-1519. PubMed ID: 36945680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.